United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$23Mraised across 3 rounds since 2007, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by deals.venturebeat.comSEC filing: $5.9M sold, first sale May 2009
BDC Capital
Western Technology InvestmentReported by ospreypharma.com
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Osprey Pharmaceuticals USA's investors include BDC Capital, GeneChem, Western Technology Investment, Desjardins Venture Capital and Burrill & Company, and 4 more on record.
Osprey Pharmaceuticals USA has raised $23M across 3 rounds since 2007.
Osprey Pharmaceuticals USA's most recent round was a Series A of $5.9M in May 2009.
Osprey Pharmaceuticals USA's largest round on record is $11M (Series A), in Sept 2008.
Osprey Pharmaceuticals USA's first round on record, in Jan 2007, was backed by BDC Capital, Desjardins Venture Capital and Ventures West and 2 others.
Osprey Pharmaceuticals USA's latest named round is a Series A, in May 2009.
Osprey Pharmaceuticals USA is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
